A Phase 3, Open-Label, Multicenter Study of the Safety

Project: Research project

Project Details

Description

A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) for the Prevention of Adenovirus (AdV) Disease
StatusFinished
Effective start/end date3/15/144/30/18

Funding

  • Chimerix, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.